Spineguard Valuation Multiples

Spineguard Overview

About Spineguard

Spineguard is engaged in the design and production of medical instruments used for spinal surgeries. It is deploying its proprietary radiation-free real time sensing technology DSG (Dynamic Surgical Guidance) to secure and streamline the placement of implants in the skeleton. It designs, develops and markets medical devices embedding its technology.

Founded

2009

HQ

Employees

19

Website

spineguard.com

Sectors

Medical DevicesHealthTech

Financials (LTM)

Revenue: $5M

EBITDA: ($947K)

EV

$12M

Valuation Multiples

Multiples.vc

Start free trial

Spineguard Financials

Spineguard reported last 12-month revenue of $5M and negative EBITDA of ($947K).

In the same LTM period, Spineguard generated ($947K) in EBITDA losses and had net loss of ($2M).

Spineguard P&L

In the most recent fiscal year, Spineguard reported revenue of $4M and EBITDA of ($1M).

Spineguard expects next 12-month revenue of XXX and NTM EBITDA of XXX

Spineguard Stock Performance

Spineguard has current market cap of $12M, and enterprise value of $12M.

Spineguard's stock price is $0.13.

Spineguard Valuation Multiples

Spineguard trades at 2.5x EV/Revenue multiple, and (12.3x) EV/EBITDA.

Spineguard Financial Valuation Multiples

As of April 20, 2026, Spineguard has market cap of $12M and EV of $12M.

Equity research analysts estimate Spineguard's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Spineguard has a P/E ratio of (6.2x).

Spineguard Margins & Growth Rates

Spineguard's revenue in the last 12 month grew by 24%.

Spineguard's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.3M for the same period.

Spineguard's rule of 40 is 20% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Spineguard's rule of X is 56% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Spineguard Public Comps

See public comps and valuation multiples for other Medical Devices comps.

Spineguard M&A Activity

Spineguard acquired XXX companies to date.

Last acquisition by Spineguard was on XXXXXXXX, XXXXX. Spineguard acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Spineguard Investment Activity

Spineguard invested in XXX companies to date.

Spineguard made its latest investment on XXXXXXXX, XXXXX. Spineguard invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).